 Seth Marder
Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Imides | 6 | 2012 | 11 | 1.480 |
Why?
| | Perylene | 4 | 2012 | 10 | 0.820 |
Why?
| | Semiconductors | 5 | 2015 | 38 | 0.660 |
Why?
| | Titanium | 2 | 2019 | 81 | 0.630 |
Why?
| | Organic Chemicals | 3 | 2013 | 127 | 0.630 |
Why?
| | Optical Phenomena | 2 | 2019 | 9 | 0.610 |
Why?
| | Ammonium Compounds | 1 | 2019 | 4 | 0.590 |
Why?
| | Calcium Compounds | 1 | 2019 | 6 | 0.590 |
Why?
| | Polymers | 8 | 2020 | 499 | 0.570 |
Why?
| | Oxides | 1 | 2019 | 51 | 0.570 |
Why?
| | Materials Science | 1 | 2018 | 2 | 0.560 |
Why?
| | Electrical Equipment and Supplies | 1 | 2018 | 9 | 0.560 |
Why?
| | Antipsychotic Agents | 3 | 2016 | 214 | 0.550 |
Why?
| | Thiophenes | 4 | 2010 | 128 | 0.480 |
Why?
| | Imidazolines | 1 | 2015 | 3 | 0.460 |
Why?
| | Naphthalenes | 2 | 2012 | 56 | 0.450 |
Why?
| | Free Radicals | 1 | 2015 | 110 | 0.440 |
Why?
| | Lurasidone Hydrochloride | 1 | 2014 | 2 | 0.440 |
Why?
| | Schizophrenic Psychology | 1 | 2014 | 97 | 0.410 |
Why?
| | Schizophrenia | 2 | 2016 | 446 | 0.410 |
Why?
| | Polycyclic Aromatic Hydrocarbons | 2 | 2011 | 29 | 0.410 |
Why?
| | Molecular Structure | 10 | 2012 | 501 | 0.400 |
Why?
| | Luminescent Agents | 1 | 2013 | 8 | 0.390 |
Why?
| | Temperature | 3 | 2013 | 679 | 0.390 |
Why?
| | Electronics | 4 | 2011 | 71 | 0.390 |
Why?
| | Lighting | 1 | 2013 | 30 | 0.380 |
Why?
| | Electrons | 7 | 2020 | 88 | 0.370 |
Why?
| | Hydrocarbons, Halogenated | 1 | 2012 | 5 | 0.370 |
Why?
| | Organotin Compounds | 1 | 2012 | 5 | 0.370 |
Why?
| | Carbazoles | 1 | 2012 | 56 | 0.360 |
Why?
| | Fluorenes | 1 | 2012 | 46 | 0.360 |
Why?
| | Models, Molecular | 6 | 2020 | 1619 | 0.330 |
Why?
| | Spectrum Analysis | 3 | 2008 | 93 | 0.320 |
Why?
| | Electron Transport | 5 | 2015 | 118 | 0.320 |
Why?
| | Quantum Theory | 5 | 2015 | 93 | 0.300 |
Why?
| | Transistors, Electronic | 3 | 2012 | 9 | 0.260 |
Why?
| | Optics and Photonics | 2 | 2005 | 41 | 0.260 |
Why?
| | Aniline Compounds | 2 | 2006 | 119 | 0.260 |
Why?
| | Nanostructures | 4 | 2013 | 117 | 0.250 |
Why?
| | Nanotechnology | 4 | 2013 | 126 | 0.240 |
Why?
| | Crystallography, X-Ray | 3 | 2015 | 493 | 0.230 |
Why?
| | Photochemical Processes | 3 | 2012 | 108 | 0.230 |
Why?
| | Organosilicon Compounds | 1 | 2005 | 3 | 0.230 |
Why?
| | Spectrophotometry, Infrared | 2 | 2004 | 55 | 0.230 |
Why?
| | Scattering, Radiation | 2 | 2004 | 103 | 0.220 |
Why?
| | Tomography, Optical | 1 | 2004 | 3 | 0.220 |
Why?
| | Connective Tissue | 1 | 2004 | 39 | 0.220 |
Why?
| | Lasers | 2 | 2004 | 132 | 0.210 |
Why?
| | Tin Compounds | 3 | 2011 | 17 | 0.210 |
Why?
| | Molecular Conformation | 3 | 2020 | 148 | 0.200 |
Why?
| | Silicon | 2 | 2013 | 22 | 0.190 |
Why?
| | Glycerides | 1 | 2002 | 17 | 0.190 |
Why?
| | Magnetic Resonance Spectroscopy | 3 | 2019 | 631 | 0.180 |
Why?
| | Fluorescent Dyes | 3 | 2011 | 330 | 0.180 |
Why?
| | Thermodynamics | 4 | 2015 | 426 | 0.180 |
Why?
| | Benzene Derivatives | 2 | 2015 | 10 | 0.170 |
Why?
| | Molybdenum | 1 | 2020 | 10 | 0.170 |
Why?
| | Disulfides | 1 | 2020 | 96 | 0.160 |
Why?
| | Oxidation-Reduction | 2 | 2015 | 1087 | 0.150 |
Why?
| | Solutions | 4 | 2013 | 167 | 0.150 |
Why?
| | Photons | 6 | 2011 | 76 | 0.150 |
Why?
| | Membranes, Artificial | 2 | 2011 | 75 | 0.150 |
Why?
| | Poloxamer | 3 | 2011 | 13 | 0.140 |
Why?
| | Stilbenes | 3 | 2006 | 33 | 0.140 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2018 | 15 | 0.140 |
Why?
| | Dimerization | 2 | 2015 | 194 | 0.130 |
Why?
| | Polymerization | 1 | 2018 | 130 | 0.130 |
Why?
| | Electrochemistry | 2 | 2009 | 74 | 0.130 |
Why?
| | Models, Chemical | 3 | 2009 | 269 | 0.130 |
Why?
| | Carotenoids | 1 | 1997 | 48 | 0.130 |
Why?
| | Catalysis | 1 | 2018 | 322 | 0.130 |
Why?
| | Drug Repositioning | 1 | 2016 | 41 | 0.120 |
Why?
| | Naphthacenes | 1 | 2015 | 3 | 0.110 |
Why?
| | Photochemistry | 3 | 2009 | 134 | 0.110 |
Why?
| | Psychotic Disorders | 1 | 2017 | 186 | 0.100 |
Why?
| | Diagnostic Imaging | 3 | 2011 | 339 | 0.100 |
Why?
| | Organophosphonates | 2 | 2011 | 97 | 0.100 |
Why?
| | Bipolar Disorder | 1 | 2017 | 280 | 0.100 |
Why?
| | Coloring Agents | 2 | 2012 | 93 | 0.100 |
Why?
| | Spectrometry, Fluorescence | 3 | 2009 | 168 | 0.090 |
Why?
| | Polycarboxylate Cement | 1 | 2012 | 4 | 0.090 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2014 | 541 | 0.090 |
Why?
| | Cognition Disorders | 1 | 2016 | 538 | 0.090 |
Why?
| | Residential Treatment | 1 | 1992 | 31 | 0.090 |
Why?
| | Imidazoles | 1 | 2013 | 254 | 0.090 |
Why?
| | Microscopy, Confocal | 2 | 2011 | 321 | 0.090 |
Why?
| | Iron Compounds | 1 | 2011 | 7 | 0.090 |
Why?
| | Surface Properties | 5 | 2013 | 410 | 0.090 |
Why?
| | Particle Size | 4 | 2009 | 411 | 0.090 |
Why?
| | Ruthenium | 1 | 2011 | 34 | 0.090 |
Why?
| | Organometallic Compounds | 1 | 2011 | 112 | 0.080 |
Why?
| | Electric Power Supplies | 1 | 2011 | 52 | 0.080 |
Why?
| | Barium Compounds | 1 | 2009 | 12 | 0.080 |
Why?
| | Polyvinyls | 1 | 2009 | 20 | 0.080 |
Why?
| | Nanocomposites | 1 | 2009 | 15 | 0.080 |
Why?
| | Electricity | 1 | 2009 | 27 | 0.080 |
Why?
| | Double-Blind Method | 1 | 2014 | 2029 | 0.080 |
Why?
| | Blood Vessels | 1 | 2011 | 171 | 0.080 |
Why?
| | Indoles | 1 | 2012 | 501 | 0.070 |
Why?
| | Cyclobutanes | 1 | 2008 | 8 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2014 | 1721 | 0.070 |
Why?
| | Diphenylamine | 1 | 2006 | 8 | 0.060 |
Why?
| | Caproates | 1 | 2006 | 5 | 0.060 |
Why?
| | Phenols | 1 | 2008 | 114 | 0.060 |
Why?
| | Ferrous Compounds | 1 | 2006 | 26 | 0.060 |
Why?
| | Alcohols | 1 | 2007 | 28 | 0.060 |
Why?
| | Benzoates | 1 | 2006 | 50 | 0.060 |
Why?
| | Carboxylic Acids | 1 | 2006 | 34 | 0.060 |
Why?
| | Crystallization | 1 | 2007 | 146 | 0.060 |
Why?
| | Acetates | 1 | 2006 | 80 | 0.060 |
Why?
| | Microscopy, Atomic Force | 1 | 2007 | 134 | 0.060 |
Why?
| | Cations | 1 | 2006 | 82 | 0.060 |
Why?
| | Electron Spin Resonance Spectroscopy | 1 | 2006 | 97 | 0.060 |
Why?
| | Silicon Dioxide | 1 | 2007 | 121 | 0.060 |
Why?
| | Online Systems | 1 | 2004 | 21 | 0.050 |
Why?
| | Crown Ethers | 1 | 2004 | 4 | 0.050 |
Why?
| | Aza Compounds | 1 | 2004 | 13 | 0.050 |
Why?
| | Computer Simulation | 1 | 2009 | 1026 | 0.050 |
Why?
| | Time Factors | 3 | 2009 | 7183 | 0.050 |
Why?
| | Hot Temperature | 1 | 2007 | 407 | 0.050 |
Why?
| | Metals | 1 | 2004 | 142 | 0.050 |
Why?
| | Nitrobenzenes | 1 | 2003 | 17 | 0.050 |
Why?
| | Octoxynol | 1 | 2002 | 13 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 1992 | 1358 | 0.050 |
Why?
| | Mental Disorders | 1 | 1992 | 1172 | 0.050 |
Why?
| | Nanoparticles | 1 | 2009 | 520 | 0.050 |
Why?
| | Spectrophotometry, Ultraviolet | 1 | 2002 | 85 | 0.050 |
Why?
| | Silver | 1 | 2003 | 38 | 0.050 |
Why?
| | Surface-Active Agents | 1 | 2002 | 92 | 0.040 |
Why?
| | Cross-Linking Reagents | 1 | 2002 | 207 | 0.040 |
Why?
| | Absorptiometry, Photon | 1 | 2003 | 276 | 0.040 |
Why?
| | Drug Therapy, Combination | 2 | 2016 | 1048 | 0.040 |
Why?
| | Rhodamines | 2 | 2011 | 21 | 0.040 |
Why?
| | Fullerenes | 2 | 2010 | 17 | 0.040 |
Why?
| | Kinetics | 2 | 2013 | 1629 | 0.040 |
Why?
| | Dextrans | 2 | 2011 | 86 | 0.040 |
Why?
| | Treatment Outcome | 1 | 2014 | 11695 | 0.040 |
Why?
| | Materials Testing | 2 | 2012 | 354 | 0.030 |
Why?
| | Fluorescence | 1 | 1998 | 161 | 0.030 |
Why?
| | Infrared Rays | 1 | 1998 | 27 | 0.030 |
Why?
| | Calmodulin-Binding Proteins | 1 | 2017 | 14 | 0.030 |
Why?
| | Chromosomes, Human, Pair 10 | 1 | 2017 | 19 | 0.030 |
Why?
| | Ankyrins | 1 | 2017 | 12 | 0.030 |
Why?
| | Excitatory Amino Acid Agents | 1 | 2016 | 5 | 0.030 |
Why?
| | Aminopeptidases | 1 | 2017 | 21 | 0.030 |
Why?
| | Cytoskeletal Proteins | 1 | 2017 | 156 | 0.030 |
Why?
| | Calcium Channels, L-Type | 1 | 2017 | 118 | 0.030 |
Why?
| | Receptors, AMPA | 1 | 2016 | 147 | 0.030 |
Why?
| | Nicotinic Agonists | 1 | 2016 | 137 | 0.030 |
Why?
| | Middle Aged | 2 | 2014 | 35928 | 0.030 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 228 | 0.030 |
Why?
| | Adult | 2 | 2014 | 40506 | 0.030 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 475 | 0.020 |
Why?
| | Nerve Tissue Proteins | 1 | 2017 | 592 | 0.020 |
Why?
| | Complex Mixtures | 1 | 2012 | 12 | 0.020 |
Why?
| | Anions | 1 | 2012 | 31 | 0.020 |
Why?
| | Salts | 1 | 2012 | 37 | 0.020 |
Why?
| | Electrodes | 1 | 2012 | 115 | 0.020 |
Why?
| | Genotype | 1 | 2017 | 1835 | 0.020 |
Why?
| | Nonlinear Dynamics | 1 | 2012 | 95 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2017 | 749 | 0.020 |
Why?
| | Styrenes | 1 | 2011 | 4 | 0.020 |
Why?
| | Blood Volume Determination | 1 | 2011 | 5 | 0.020 |
Why?
| | Humans | 5 | 2017 | 144957 | 0.020 |
Why?
| | Stereoisomerism | 1 | 2011 | 105 | 0.020 |
Why?
| | Micelles | 1 | 2011 | 40 | 0.020 |
Why?
| | Marriage | 1 | 1992 | 122 | 0.020 |
Why?
| | Absorption | 1 | 2010 | 60 | 0.020 |
Why?
| | Silanes | 1 | 2010 | 18 | 0.020 |
Why?
| | California | 1 | 1992 | 475 | 0.020 |
Why?
| | Employment | 1 | 1992 | 188 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 157 | 0.020 |
Why?
| | Neoplasms, Experimental | 1 | 2011 | 173 | 0.020 |
Why?
| | Patient Admission | 1 | 1992 | 218 | 0.020 |
Why?
| | Educational Status | 1 | 1992 | 467 | 0.020 |
Why?
| | Genome-Wide Association Study | 1 | 2017 | 1407 | 0.020 |
Why?
| | Thermogravimetry | 1 | 2009 | 6 | 0.020 |
Why?
| | Phosphoric Acids | 1 | 2009 | 17 | 0.020 |
Why?
| | Halogenation | 1 | 2009 | 23 | 0.020 |
Why?
| | Male | 2 | 2014 | 72406 | 0.020 |
Why?
| | Equipment Design | 1 | 2011 | 530 | 0.020 |
Why?
| | Regression Analysis | 1 | 1992 | 1003 | 0.020 |
Why?
| | Spectroscopy, Fourier Transform Infrared | 1 | 2009 | 88 | 0.020 |
Why?
| | Surface Tension | 1 | 2009 | 10 | 0.020 |
Why?
| | Spectrophotometry | 1 | 2009 | 61 | 0.020 |
Why?
| | Luminescence | 1 | 2009 | 39 | 0.020 |
Why?
| | Psychiatry | 1 | 1992 | 195 | 0.020 |
Why?
| | Electric Impedance | 1 | 2009 | 111 | 0.020 |
Why?
| | Mice, Nude | 1 | 2011 | 688 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2017 | 2147 | 0.020 |
Why?
| | Luminescent Measurements | 1 | 2009 | 76 | 0.020 |
Why?
| | Female | 2 | 2014 | 78376 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2017 | 3608 | 0.020 |
Why?
| | Phenotype | 1 | 2017 | 3164 | 0.020 |
Why?
| | Interviews as Topic | 1 | 1992 | 901 | 0.020 |
Why?
| | Cognition | 1 | 2016 | 1269 | 0.020 |
Why?
| | Vibration | 1 | 2008 | 71 | 0.020 |
Why?
| | Brain | 2 | 2011 | 2941 | 0.020 |
Why?
| | Ligands | 1 | 2009 | 674 | 0.020 |
Why?
| | Metallocenes | 1 | 2006 | 3 | 0.020 |
Why?
| | Hydroxylation | 1 | 2007 | 49 | 0.020 |
Why?
| | X-Ray Diffraction | 1 | 2007 | 104 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2007 | 224 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2007 | 199 | 0.020 |
Why?
| | Adsorption | 1 | 2006 | 157 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 1253 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 1992 | 2947 | 0.010 |
Why?
| | Light | 1 | 2006 | 411 | 0.010 |
Why?
| | Water | 1 | 2006 | 469 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2011 | 3550 | 0.010 |
Why?
| | Mice | 2 | 2011 | 18365 | 0.010 |
Why?
| | Kidney | 1 | 2009 | 1496 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3415 | 0.010 |
Why?
| | Liver | 1 | 2009 | 1888 | 0.010 |
Why?
| | Chemistry, Physical | 1 | 1998 | 39 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1998 | 81 | 0.010 |
Why?
| | Birefringence | 1 | 1998 | 7 | 0.010 |
Why?
| | Refractometry | 1 | 1998 | 31 | 0.010 |
Why?
| | Animals | 2 | 2011 | 38109 | 0.010 |
Why?
| | Image Processing, Computer-Assisted | 1 | 1998 | 781 | 0.010 |
Why?
| | Adolescent | 1 | 1992 | 22453 | 0.010 |
Why?
| | Aged | 1 | 1992 | 25947 | 0.010 |
Why?
|
|
Marder's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|